Biomedical Research Associate
Current• Developed Fructose microparticles delivering agonists to dendritic cells, activating them via sugar and agonist presentation• Used process filtration techniques to purify microparticles from unreacted materials, assessing purity via chromatography• Conducted biological evaluations of vaccine in compliance with ISO 10993 standards, ensuring no adverse cellular responses• Scaled up vaccine production from grams to kilograms while ensuring nano-scale quality of the vaccine batches produced• Refined the technology's market segment by meeting with and developing relationships with hospital directors and physicians